ScoreWhy is Yabao Pharmaceutical Group Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of -1.90% and Operating profit at 3.95% over the last 5 years
2
Negative results in Jun 25
- OPERATING CASH FLOW(Y) Lowest at CNY 458.78 MM
- NET SALES(Q) Lowest at CNY 516.42 MM
3
With ROE of 8.09%, it has a attractive valuation with a 1.79 Price to Book Value
- Over the past year, while the stock has generated a return of 5.07%, its profits have risen by 18.6% ; the PEG ratio of the company is 1.2
- At the current price, the company has a high dividend yield of 4.6
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Yabao Pharmaceutical Group Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Yabao Pharmaceutical Group Co., Ltd. for you?
Medium Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Yabao Pharmaceutical Group Co., Ltd.
5.07%
0.61
25.92%
China Shanghai Composite
14.77%
1.01
14.58%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-1.90%
EBIT Growth (5y)
3.95%
EBIT to Interest (avg)
20.35
Debt to EBITDA (avg)
0.20
Net Debt to Equity (avg)
-0.19
Sales to Capital Employed (avg)
0.86
Tax Ratio
22.17%
Dividend Payout Ratio
88.24%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
6.87%
ROE (avg)
5.84%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
22
Industry P/E
Price to Book Value
1.79
EV to EBIT
17.42
EV to EBITDA
11.38
EV to Capital Employed
1.97
EV to Sales
1.91
PEG Ratio
1.19
Dividend Yield
4.62%
ROCE (Latest)
11.28%
ROE (Latest)
8.09%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bullish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend6What is working for the Company
ROCE(HY)
Highest at 8.36%
DEBT-EQUITY RATIO
(HY)
Lowest at -18.35 %
RAW MATERIAL COST(Y)
Fallen by 1.46% (YoY
INVENTORY TURNOVER RATIO(HY)
Highest at 3.28%
-15What is not working for the Company
OPERATING CASH FLOW(Y)
Lowest at CNY 458.78 MM
NET SALES(Q)
Lowest at CNY 516.42 MM
Here's what is working for Yabao Pharmaceutical Group Co., Ltd.
Debt-Equity Ratio
Lowest at -18.35 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Inventory Turnover Ratio
Highest at 3.28%
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Raw Material Cost
Fallen by 1.46% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Yabao Pharmaceutical Group Co., Ltd.
Net Sales
At CNY 516.42 MM has Fallen at -17.26%
over average net sales of the previous four periods of CNY 624.13 MMMOJO Watch
Near term sales trend is extremely negative
Net Sales (CNY MM)
Operating Cash Flow
Lowest at CNY 458.78 MM
in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (CNY MM)
Net Sales
Lowest at CNY 516.42 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (CNY MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
